The Conclusio team works across boundaries; a compact group of cross-sector professionals with a combined experience of over 200 years.

Understanding health and care systems is a core discipline at Conclusio and all its associates are experienced in the decision-making landscape. This means that we can advise at the optimal level and deliver.

Core Team

James Roach

James Roach

Founder & Managing Director

Mike Proctor

Mike Proctor

Non-Executive Chair

Anant Jani

Anant Jani

Director of Clinical Insights

Jeremy Hooper

Jeremy Hooper

Health Economics & Intelligence Consultant

Johnny Skillicorn-Aston MCIPR

Johnny Skillicorn-Aston MCIPR

Communications & Engagement Consultant

Caroline Howden

Caroline Howden

Client Delivery Lead

James Roach

Founder & Managing Director

James has led a number of national transformation programmes, launched several national reports and has brokered and led partnership initiatives across NHS and the Pharmaceutical Industry.

James is experienced as an NHS Director who, over the last 10 years, has led systems through operational transformation, delivering innovative programmes of health and social care in a range of settings and roles.

He is passionate about clinical innovation and developing impactful relationships across the health, care pharmacy and patient interface and across the wider health and social care supply chain.

Mike Proctor

Non-Executive Chair

Mike has 45 years of experience gained within the NHS, half of which were spent in senior executive roles that included Chief Nurse, Chief Operating Officer, Deputy Chief Executive and Chief Executive.  Mike retired from his substantive NHS role as Chief Executive of York Foundation Trust 11 months ago and joins Conclusio from his most recent role as interim chief operating officer at North Cumbria Trust.
As a high profile healthcare leader Mike has advised healthcare systems across Europe and North America.

Anant Jani

Director of Clinical Insights

Anant is currently an Oxford Martin Fellow at the University of Oxford.  His work focuses on how to reorient healthcare systems to focus more on population health - namely, keeping people healthy and preventing them from getting sick.  Prior to his role at Oxford, Anant was Executive Director at Better Value Healthcare, a working with governments in the UK, Europe, Middle East and Southeast Asia to help them redesign their healthcare systems to focus more on value based healthcare.  He received his PhD from Yale University and BSc from Brandeis University.

As an academic clinician, Anant will work with the pharma industry and heath systems to define clinical outcomes that matter to patients, advise on how the use of real world outcomes data will inform the design and optimisation of care pathways and therapeutic regimens and position clinical outcomes to highlight the value proposition of products and services.

Jeremy Hooper

Health Economics & Intelligence Consultant

Jeremy has a degree in Statistics and a Masters in Corporate Administration, He has been a Graduate and Associate member of the Institute of Chartered Secretaries and Administrators for over 15 years.

Jeremy has worked on the analysis of large and complex data sets in the Defence and Health Sectors internationally  for over 25 years.  As part of this he has built predictive models for understanding the cost of ownership of large systems of systems as part of defence procurement. He has also built demand models to support NHS contract negotiations. He has recently built a demand model for Adult Social Care for a Local Authority in the South West of England. 

Jeremy has supported evaluation and performance reporting helping a number of Public Sector organisation understand their performance and how that can be used to improve outcomes for the organisation and patients.

Johnny Skillicorn-Aston MCIPR

Communications & Engagement Consultant

Johnny has a quarter of a century of experience in developing and delivering communication strategies for the public and private sectors and for civil society organisations.

He has supported large-scale transformation projects UK and globally working with both health providers and commissioners, designing communication plans and campaigns to drive effective relationship management within health and social care systems. He has influenced, developed and delivered  consultation methodologies and strategies across policymakers, payers, clinical professionals and the public.

Johnny has authored public engagement campaigns for a range of medicines and services and elicit support for clinical, social and policy change.

He has delivered corporate communications programme for the pharmaceutical industry.

Caroline Howden

Client Delivery Lead

Caroline has over 20 years experience working across the NHS, local government, public and private sectors in programme and project management; client relationship management and partnership working.  Caroline has also provided programme leadership and policy development in healthcare systems in the UK and large global entities such as G4S, Mitie and Virgin Healthcare.

Caroline has developed and lead complex partnerships across health and care, involving both the public and private sectors; including working with MPs and elected representatives, increasing their awareness of delivery of health and care outcomes at community level.

Associates Team

Amit Patel

Primary Care Partnership Consultant

Andrew Lane MRPharmS

Clinical Director

Amit Patel

Primary Care Partnership Consultant

Amit is an experienced CEO with a history of working in the not-for-profit sector. His experience in senior management roles has been gained within health services, primary care and professional development.   He is the current CEO of Pharmacy London and leads on pricing and commercial strategies for industry.

Andrew Lane MRPharmS

Clinical Director

Andrew is Chair of the National Pharmacy Association (NPA) in the UK.

Andrew has wide experience owning and operating Community Pharmacies across England. He was immediate past President of the European Pharmacist Forum and a member of the world pharmacy council.  Andrew has been at the forefront of clinical service and policy change across  Europe.